1. Bendotti, C., Tortarolo, M., Suchak, S.K., Calvaresi, N., Carvelli, L., Bastone, A., Rizzi, M., Rattray, M., Mennini, T. Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels. J Neurochem 2001. 79: 737–746.
2. Bigini, P., Bastone, A., Mennini, T. Glutamate transporters in the spinal cord of the wobbler mouse. Neuroreport 2001. 12:1815–1820.
3. Bristol, L.A., Rothstein, J.D. Glutamate transporter gene expression in amyotrophic lateral sclerosis motor cortex. Ann Neurol 1996. 39: 676–679.
4. Bronson, R.T., Donahue, L.R., Johnson, K.R., Tanner, A., Lane, P.W., Faust, J.R. Neuronal ceroid lipofuscinosis (nclt), a new disorder of the mouse linked to chromosome 9. Am J Med Gen 1998. 77: 289–297.
5. Canton, T., Bohme, G.A., Boireau, A., Bordier, F., Mignani, S., Jimonet, P., Jahn, G., Alavijeh, M., Stygall, J., Roberts, S., Brealey, C., Vuilhorgne, M., Debono, M.W., Le Guern, S., Laville, M., Briet, D., Roux, M., Stutzmann, J.-M., Pratt, J. RPR 119990, a Novel alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Antagonist: Synthesis, Pharmacological Properties, and Activity in an Animal Model of Amyotrophic Lateral Sclerosis. J Pharmacol Exp Ther 2001. 299: 314–322.